The MELODY Study

Evaluation of Lateral Flow Tests to assess Covid-19 antibodies in Immunosuppressed People

COVID-19 remains a threat, particularly to some groups such as transplant recipients and other immunosuppressed people.



This research study will help scientists and the Government assess the effectiveness of the third COVID-19 vaccination or “booster” vaccination programme among immunosuppressed people. A 6 month follow up will see how many Covid infections have been reported in the trial groups.



If you’ve had a solid organ transplant (e.g. lung, liver, kidney), are taking medication to suppress your immune system and have received your third COVID-19 vaccination or “booster” vaccination, you can register to take part. Visit www.melodystudy.org to find out more about taking part.



The study will involve completing a health questionnaire and a finger-prick antibody test which will be sent to you. Follow up, to see if any Covid-19 infections have been reported since enrolment, will be via the UK Transplant Registry for 6 months.